CANCER SCREENING IN THE ELDERLY POPULATION

Adam, 1998, Is human papillomavirus testing an effective triage method for detection of high grade (grade 2 or 3) cervical intraepithelial neoplasia?, Am J Obstet Gynecol, 178, 1235, 10.1016/S0002-9378(98)70328-X Adam, 1998, Ovarian cancer screening, Semin Oncol, 25, 315 Addler, 1995, New methods for imaging the breast: Techniques, findings, and potential, AJR Am J Roentgenol, 164, 19, 10.2214/ajr.164.1.7998538 Ahrendt, 1999, Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer, J Natl Cancer Inst, 91, 332, 10.1093/jnci/91.4.332 Ahsan, 1998, Family history of colorectal adenomatous polyps and increased risk for colorectal cancer, Ann Intern Med, 128, 900, 10.7326/0003-4819-128-11-199806010-00006 Albertson, 1995, Long term survival among men with conservatively treated prostate cancer, JAMA, 274, 626, 10.1001/jama.274.8.626 American College of Obstetricians and Gynecologists, 1996 American College of Radiology, 1998 Andersson, 1988, Mammographic screening and mortality from breast cancer: The Malmo mammographic screening trial, BMJ, 297, 943, 10.1136/bmj.297.6654.943 American College of Physicians, 1997, Guidelines for screening for prostate cancer, Ann Intern Med, 126, 480, 10.7326/0003-4819-126-6-199703150-00011 Arcangeli, 1997, Prostate-specific antigen as a screening test for prostate cancer. The United States experience, Urol Clin North Am, 24, 299, 10.1016/S0094-0143(05)70376-1 Atkins, 1993, Prevention of colorectal cancer by once only sigmoidoscopy, Lancet, 341, 736, 10.1016/0140-6736(93)90499-7 Balducci, 1991, Breast cancer of the older woman: An annotated review, J Am Geriatr Soc, 39, 1113, 10.1111/j.1532-5415.1991.tb02879.x Bangma, 1997, Prostate specific antigen as a screening test: The Netherlands experience, Urol Clin North Am, 24, 307, 10.1016/S0094-0143(05)70377-3 Baron, 1999, Calcium supplements for the prevention of colorectal adenomas, N Engl J Med, 340, 101, 10.1056/NEJM199901143400204 Basler, 1998, Lest we abandon digital rectal examination as a screening test for prostate cancer, J Natl Cancer Inst, 90, 1761, 10.1093/jnci/90.23.1761 Bazinet, 1996, Value of systematic transition zone biopsies in the early detection of prostate cancer, J Urol, 155, 605, 10.1016/S0022-5347(01)66463-2 Beahrs, 1979, Report of the working group to review the National Cancer Institute American Cancer Society breast cancer detection demonstration projects, J Natl Cancer Inst, 62, 639 Berlin, 1984, National Cancer Institute Lung Cancer Detection Program: Results of initial screen (prevalence)–early cancer detection, American Review of Respiratory Disease, 130, 545 Berlin, 1975, An overview of research in cancer diagnosis, Mayo Clin Proc, 50, 249 Basselt, 1991, The prevalence of carcinoma in palpable versus impalpable mammographically detected lesions, AJR Am J Roentgenol, 157, 21, 10.2214/ajr.157.1.1646562 Black, 1996, Effects of estrogen on screening mammography: Another complexity, J Natl Cancer Inst, 88, 627, 10.1093/jnci/88.10.627 Bondy, 1994, Re: Validation of the Gail et al model for predicting individual breast cancer risk, J Natl Cancer Inst, 86, 1350, 10.1093/jnci/86.17.1350-c Borer, 1996, Age specific reference ranges for prostatic specific antigen and digital rectal exam may not safely eliminate further diagnostic procedures, J Urol, 155, 322A Bosch, 1995, Prevalence of human papillomavirus in cervical cancer: A worldwide perspective, J Natl Cancer Inst, 87, 796, 10.1093/jnci/87.11.796 Bova, 1998, PC Biological aggressiveness of hereditary prostate cancer: Long-term evaluation following radical prostatectomy, J Urol, 160, 660, 10.1016/S0022-5347(01)62748-4 Boyd, 1995, Quantitative classification of mammographic densities and breast cancer risk: Results from the Canadian National Breast Screening Study, J Natl Cancer Inst, 87, 670, 10.1093/jnci/87.9.670 Boyd, 1997, Efforts at two years of a low fat high carbohydrate diet on radiologic features of the breast: Results from a randomized trial, J Natl Cancer Inst, 89, 488, 10.1093/jnci/89.7.488 Brawer, 1998, Measurement of complexed PSA improves specificity for early detection of prostate cancer, Urology, 52, 372, 10.1016/S0090-4295(98)00241-6 Breen, 1994, Change in the use of screening mammography: Evidence from the 1987 and 1990 National Health Interview Survey, Am J Public Health, 84, 62, 10.2105/AJPH.84.1.62 Brown, 1992, Terazocin and Finasteride both lower serum PSA level in men with benign prostatic hyperplasia, J Urol, 147, 841 Byers, 1997, American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer update 1997. American Cancer Society detection and treatment advisory group on colorectal cancer, CA Cancer J Clin, 47, 154, 10.3322/canjclin.47.3.154 Cadman, 1984, Assessing the effectiveness of community screening programs, JAMA, 251, 1580, 10.1001/jama.251.12.1580 Cady, 1998, Evaluation of common breast problems: Guidance for primary care providers, CA Cancer J Clin, 48, 49, 10.3322/canjclin.48.1.49 Carter, 1999, Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable disease, Urology, 53, 126, 10.1016/S0090-4295(98)00466-X Carter, 1995, Prostate-specific antigen variability in men without prostate cancer: Effect of sampling interval on prostate-specific antigen velocity, Urology, 45, 591, 10.1016/S0090-4295(99)80049-1 Carvalhal, 1999, Digital rectal examination for detecting prostate cancer at PSA levels 4ng/ml or less, J Urol, 161, 835, 10.1016/S0022-5347(01)61785-3 Catalona, 1998, Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: A prospective multicenter clinical trial, JAMA, 279, 1542, 10.1001/jama.279.19.1542 Catalona, 1994, Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: Receiver operating characteristic curves, J Urol, 152, 2031, 10.1016/S0022-5347(17)32299-1 Celentano, 1989, Duration of relative protection of screening for cervical cancer, Prev Med, 18, 411, 10.1016/0091-7435(89)90001-7 Charlson, 1987, A new method of classifying prognostic comorbidity in longitudinal studies development and validation, Journal of Chronic Diseases, 40, 373, 10.1016/0021-9681(87)90171-8 Chodak, 1989, Assessment of screening for prostate cancer using the digital rectal examination, J Urol, 141, 1136, 10.1016/S0022-5347(17)41192-X Chodak, 1994, Results of conservative management of clinically localized prostate cancer, N Engl J Med, 330, 242, 10.1056/NEJM199401273300403 Cohen, 1997, Cancer of colon, 1144 Cohen, 1999, Oncology and aging: General principles of cancer in the elderly, 117 Cole, 1980, Basic issues in population cancer screening, J Natl Cancer Inst, 64, 1263 Coley, 1997, Early detection of prostate cancer. I. Prior probability and effectiveness of tests, Ann Intern Med, 126, 394, 10.7326/0003-4819-126-5-199703010-00010 1997, Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiologic studies of 52,705 women with breast cancer and 108,411 without breast cancer, Lancet, 350, 1047, 10.1016/S0140-6736(97)08233-0 Constanza, 1994, Issues in breast cancer screening in older women, Cancer, 74, 2009, 10.1002/1097-0142(19941001)74:7+<2009::AID-CNCR2820741704>3.0.CO;2-E Cooper, 1979, Describing the validity of carcinogen screening tests, Br J Cancer, 39, 87, 10.1038/bjc.1979.10 Costanza, 1992, Breast cancer screening in older women: Synopsis of a form, Cancer, 69, 1925, 10.1002/1097-0142(19920401)69:7+<1925::AID-CNCR2820691709>3.0.CO;2-U Covacci, 1999, Helicobacter pylori virulence and genetic geography, Science, 284, 1328, 10.1126/science.284.5418.1328 Crawford, 1999, Efficiency of prostate-specific antigen and digital rectal examination in screening, using 4.0 ng/ml and age-specific reference range as a cutoff for abnormal values, Prostate, 38, 296, 10.1002/(SICI)1097-0045(19990301)38:4<296::AID-PROS5>3.0.CO;2-P Creditor, 1993, Hazards of hospitalization of the elderly, Ann Intern Med, 118, 219, 10.7326/0003-4819-118-3-199302010-00011 Critchlow, 1999, Old and new issues in cervical cancer control, J Natl Cancer Inst, 91, 200, 10.1093/jnci/91.3.200 D'Amico, 1998, A biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer, JAMA, 280, 969, 10.1001/jama.280.11.969 Einhorn, 1992, Prospective evaluation of Ca 125 levels for early detection of ovarian cancer, Obstet Gynecol, 80, 14 Elmore, 1998, Ten year risk of false positive screening mammograms and clinical breast examinations, N Engl J Med, 338, 1089, 10.1056/NEJM199804163381601 Epstein, 1997, Pathology of adenocarcinoma of the prostate, 2497 Ernster, 1996, Incidence of and treatment for ductal carcinoma in situ of the breast, JAMA, 275, 913, 10.1001/jama.275.12.913 Espana, 1998, Free and complexed prostate specific antigen in the differentiation of benign prostatic hyperplasia and prostate cancer: Studies in serum and plasma samples, J Urol, 160, 2081, 10.1016/S0022-5347(01)62248-1 Essink-Bot, 1998, Short term effect of population based screening for prostate cancer on health related quality of life, J Natl Cancer Inst, 70, 925, 10.1093/jnci/90.12.925 Everett, 1998, Early gastric cancer: Disease or pseudo-disease?, Lancet, 351, 1350, 10.1016/S0140-6736(98)04365-7 Evers, 1994, Organ physiology of aging, Surg Clin North Am, 74, 23, 10.1016/S0039-6109(16)46226-2 Farkas, 1998, National trends in the epidemiology of prostate cancer: 1973–1994: Evidence for the effectiveness of prostate-specific antigen screening, Urology, 52, 444, 10.1016/S0090-4295(98)00242-8 Faulk, 1995, Clinical efficacy of mammographic screening in the elderly, Radiology, 194, 193, 10.1148/radiology.194.1.7997552 Feig, 1997, Increased benefit from shorter mammography screening intervals for women age 40–49 years, Cancer, 80, 2035, 10.1002/(SICI)1097-0142(19971201)80:11<2035::AID-CNCR1>3.0.CO;2-W Feig, 1999, Role and evaluation of mammography and other imaging methods for breast cancer detection, diagnosis, and staging, Semin Nucl Med, 29, 3, 10.1016/S0001-2998(99)80026-9 Feuer, 1993, The lifetime risk of developing breast cancer, J Natl Cancer Inst, 85, 892, 10.1093/jnci/85.11.892 Fletcher, 1993, Report of the International Workshop on cancer screening for breast cancer, J Natl Cancer Inst, 85, 1644, 10.1093/jnci/85.20.1644 Foutch, 1991, Flexible sigmoidoscopy may be ineffective for secondary prevention of colorectal cancer in asymptomatic average risk men, Dig Dis Sci, 36, 924, 10.1007/BF01297142 Fox, 1991, The impact of physician compliance on screening mammography for older women, Arch Intern Med, 151, 50, 10.1001/archinte.151.1.50 Fuchs, 1994, A prospective study of family history and risk of colorectal cancer, N Engl J Med, 331, 1669, 10.1056/NEJM199412223312501 Fuchs, 1999, Dietary fiber and the risk of colorectal cancer and adenoma in woman, N Engl J Med, 340, 169, 10.1056/NEJM199901213400301 Fuchs, 1995, Gastric carcinoma, N Engl J Med, 333, 32, 10.1056/NEJM199507063330107 Galloway, 1994, Papilloma virus capside: A new approach to identify serological markers of HPV infection, J Natl Cancer Inst, 86, 474, 10.1093/jnci/86.7.474 Gann, 1994, Prospective study of plasma fatty acids and risk of prostate cancer, J Natl Cancer Inst, 86, 281, 10.1093/jnci/86.4.281 Gann, 1995, A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer, JAMA, 273, 289, 10.1001/jama.273.4.289 Greenberg, 1993, Diagnostic testing, 63 Greenstein, 1979, Cancer in universal and left sided ulcerative colitis factors determining risk, Gastroenterology, 77, 290, 10.1016/0016-5085(79)90279-8 Hardcastle, 1996, Randomized controlled trial of fecal occult-blood screening for colorectal cancer, Lancet, 348, 1472, 10.1016/S0140-6736(96)03386-7 Harris, 1997, Prospective longitudinal evaluation of men with initial prostate specific antigen levels of 4.0 ng/ml or less, J Urol, 157, 1740, 10.1016/S0022-5347(01)64848-1 Harvey, 1997, Short term cessation of hormone replacement therapy and improvement of mammographic specificity, J Natl Cancer Inst, 89, 1623, 10.1093/jnci/89.21.1623 Henderson, 1992, Biologic variation of tumors, Cancer, 69, 1888, 10.1002/1097-0142(19920401)69:7+<1888::AID-CNCR2820691703>3.0.CO;2-# Herrero, 1992, Screening for cervical cancer in Latin America: A case control study, Int J Epidemiol, 21, 1050, 10.1093/ije/21.6.1050 Hoh, 1999, 18-FDG imaging in breast cancer, Semin Nucl Med, 29, 49, 10.1016/S0001-2998(99)80029-4 Holden, 1996, Live long and prosper, Science, 273, 42 Holowaty, 1999, Natural history of dysplasia of the uterine cervix, J Natl Cancer Inst, 91, 252, 10.1093/jnci/91.3.252 Hulka, 1988, Cancer screening: Degrees of proof and practical application, Cancer, 62, 1776, 10.1002/1097-0142(19881015)62:1+<1776::AID-CNCR2820621314>3.0.CO;2-V Hunter, 1987, Selection factors in clinical trials: Results from the community clinical oncology program physicians patient log, Cancer Treatment Reports, 71, 559 Itoh, 1998, Screening of helical CT for mass screening of lung cancer: Application low dose and single breath-hold scanning, Radiat Med, 16, 75 Jackson, 1999, The epidemiology of aging, 203 Jacobs, 1996, Risk of diagnosis of ovarian cancer after raised serum CA125 concentration; a prospective cohort study, BMJ, 313, 1355, 10.1136/bmj.313.7069.1355 Jacobs, 1999, Radial scars in benign breast-biopsy specimens and the risk of breast cancer, N Engl J Med, 340, 430, 10.1056/NEJM199902113400604 Jen, 1998, Molecular approaches for colorectal cancer screening. Eur J, Gastroenterol Hepatol, 10, 213, 10.1097/00042737-199803000-00004 Johansson, 1997, Fifteen year survival in prostate cancer, JAMA, 277, 467, 10.1001/jama.277.6.467 Kanamori, 1998, Residual disease and presence of human papillomavirus after conization, Oncology, 55, 517, 10.1159/000011905 Kant, 1992, Does cancer survival differ for older patients?, Cancer, 70, 2734, 10.1002/1097-0142(19921201)70:11<2734::AID-CNCR2820701127>3.0.CO;2-F Kelsey, 1993, Breast cancer epidemiology: Summary and future directions, Epidemiol Rev, 15, 256, 10.1093/oxfordjournals.epirev.a036112 Kerlikowske, 1996, Effect of age, breast density and family history in the sensitivity of first screening mammography by age and family history of breast cancer, JAMA, 276, 33, 10.1001/jama.276.1.33 Kerlikowske, 1993, Positive predictive value of screening mammography by age and family history of breast cancer, JAMA, 270, 2444, 10.1001/jama.270.20.2444 Kerlikowske, 1995, Efficacy of screening mammography: A meta-analysis, JAMA, 273, 149, 10.1001/jama.273.2.149 Kimmick, 1997, Breast cancer in older women, Clin Geriatr Med, 13, 265, 10.1016/S0749-0690(18)30169-1 Kirk, 1998, Prostate cancer in the elderly, Eur J Surg Oncol, 24, 379, 10.1016/S0748-7983(98)92031-5 Kiviat, 1992, Reassessment of the morphological continuum of cervical intraepithelial lesions: Does it reflect different stages in the progression to cervical carcinoma?, International Agency for Research on Cancer Science Publishing, 119, 59 Klatsky, 1988, The relations of alcoholic beverage to colon and rectal cancer, Am J Epidemiol, 128, 1007, 10.1093/oxfordjournals.aje.a115045 Kleinman, 1981, Who is being screened for cervical cancer?, Am J Public Health, 71, 73, 10.2105/AJPH.71.1.73 Kopans, 1996, The positive predictive value of mammographically initiated breast screenings: There is no abrupt change at 50 years, Radiology, 200, 357, 10.1148/radiology.200.2.8685325 Kronborg, 1996, Randomized study of screening for colorectal cancer with fecal-occult-blood test, Lancet, 348, 1467, 10.1016/S0140-6736(96)03430-7 Kurjak, 1992, Transvaginal ultrasound, color flow and doppler waveform of the post menopausal adnexal mass, Obstet Gynecol, 80, 917 Kurman, 1994 Kurman, 1994, Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop, JAMA, 271, 1866, 10.1001/jama.271.23.1866 Laken, 1997, Familial colorectal cancer in Askenazim due to a hypermutable tract in APC, Nat Genet, 17, 7983, 10.1038/ng0997-79 Landis, 1999, Cancer Statistics, CA Cancer J Clin, 49, 8, 10.3322/canjclin.49.1.8 Lane, 1999, Current perspective on physician barriers to breast cancer screening, J Am Board Fam Pract, 12, 8, 10.3122/15572625-12-1-8 Larsson, 1996, The Swedish randomized trial: Analyses of the effect on the breast cancer related excess mortality, J Med Screen, 3, 129, 10.1177/096914139600300305 Law, 1996, Breast cancer in elderly women: Presentation, survival, and treatment options, Surg Clin North Am, 76, 289, 10.1016/S0039-6109(05)70440-0 Lawton, 1991, A multidimensional view of quality of life in frail elderly Laya, 1996, Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography, J Natl Cancer Inst, 88, 643, 10.1093/jnci/88.10.643 Leitch, 1997, American Cancer Society for the Early Detection of Breast Cancer, CA Cancer J Clinic, 47, 150, 10.3322/canjclin.47.3.150 Lerman, 1991, Psychological side effects of breast cancer screening, Health Psychol, 10, 259, 10.1037/0278-6133.10.4.259 Levin, 1999, Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy, JAMA, 281, 1611, 10.1001/jama.281.17.1611 Liberman, 1998, The breast image reporting and data systems positive predictive value of mammographic features and final assessment categories, AJR Am J Roentgenol, 171, 35, 10.2214/ajr.171.1.9648759 Lieberman, 1995, Cost effectiveness model for colon cancer screening, Gastroenterology, 109, 1781, 10.1016/0016-5085(95)90744-0 Lilienfield, 1974, Some limitations and problems of screening for cancer, Cancer, 33, 1720, 10.1002/1097-0142(197406)33:6+<1720::AID-CNCR2820330705>3.0.CO;2-1 Linver, 1997, Mammography outcome in a practice setting by age: Prognostic factors, sensitivity, positive biopsy rate, Monograph National Cancer Institute, 22, 113, 10.1093/jncimono/1997.22.113 Lippman, 1998, Cancer chemo prevention: Programs and promise, J Natl Cancer Inst, 90, 1514, 10.1093/jnci/90.20.1514 Lissner, 1996, Physical activity levels and changes in relation to longevity, Am J Epidemiol, 143, 54, 10.1093/oxfordjournals.aje.a008657 Litwin, 1999, Health related quality of life in older men without prostate cancer, J Urol, 161, 1180, 10.1016/S0022-5347(01)61624-0 Lodding, 1998, Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng/ml prostate specific antigen, J Urol, 159, 899, 10.1016/S0022-5347(01)63766-2 Lu-Yao, 1997, Population-based study of long-term survival in patients with clinically localised prostate cancer, Lancet, 349, 906, 10.1016/S0140-6736(96)09380-4 Lynch, 1998, An update of Lynch syndrome (HNPCC), Curr Opin Oncol, 10, 349, 10.1097/00001622-199807000-00012 Madel, 1999, Colorectal cancer mortality effectiveness of biennial screening for fecal occult blood, J Natl Cancer Inst, 91, 434, 10.1093/jnci/91.5.434 Mandel, 1989, Sensitivity, specificity and positive predictivity of the Hemoccult test in screening for colorectal cancers: The University of Minnesota's Colon Cancer Control Study, Gastroenterology, 97, 597, 10.1016/0016-5085(89)90629-X Mandel, 1993, Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study, N Engl J Med, 328, 1365, 10.1056/NEJM199305133281901 Mandelblatt, 1992, Breast cancer screening for elderly women with and without comorbid conditions. A decision analysis model, Ann Intern Med, 116, 722, 10.7326/0003-4819-116-9-722 Mashberg, 1984, Screening for oral oropharyngeal squamous carcinomas, CA Cancer J Clin, 34, 262, 10.3322/canjclin.34.5.262 Matsakura, 1995, Identification of genital human papilloma viruses in cervical biopsy specimens: Segregation of specific virus type in specific clinicopathologic lesions, Int J Cancer, 61, 13, 10.1002/ijc.2910610104 McCarthy, 1998, Mammography use helps to explain differences in breast cancer stage at diagnosis between older black and white women, Ann Intern Med, 128, 729, 10.7326/0003-4819-128-9-199805010-00005 McCarty, 1983, Relationship of age and menopausal status to estrogen receptor content in primary carcinoma of the breast, Ann Surg, 197, 123, 10.1097/00000658-198302000-00001 McCoy, 1994, Breast cancer screening of the medically underserved. Results and implications, Cancer Practice, 2, 267 McDivitt, 1992, Histologic types of benign breast disease and the risk of breast cancer, Cancer, 69, 1408, 10.1002/1097-0142(19920315)69:6<1408::AID-CNCR2820690617>3.0.CO;2-C McGregor, 1998, Screening for prostate cancer: Estimating the magnitude of overdetection, CMAJ, 159, 1368 McTiernan, 1997, Assessing individual risk for breast cancer: Risky business, J Clin Epidemiol, 50, 547, 10.1016/S0895-4356(97)00013-9 Mettlin, 1993, Defining and updating the American Cancer Society guidelines for the cancer related check up: Prostate and endometrial cancers, CA Cancer J Clin, 43, 42, 10.3322/canjclin.43.1.42 Meyer, 1998, Prostate cancer: 4. Screening, CMAJ, 159, 968 Meyer, 1979, Advanced stage and early relapse of breast carcinoma associated with high thymidine labeling indices, Cancer Res, 39, 4042 Mitra, 1994, Breast screening. The case for physical examination without mammography, Lancet, 343, 342, 10.1016/S0140-6736(94)91170-3 Morrison, 1979, The public health value of using epidemiologic information to identify high risk groups for bladder cancer screening, Semin Oncol, 6, 184 Mukherjee, 1999, Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression, J Natl Cancer Inst, 91, 512, 10.1093/jnci/91.6.512 Nadler, 1995, Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels, J Urol, 154, 407, 10.1016/S0022-5347(01)67064-2 Nagler, 1999, Early diagnosis and treatment monitoring roles of tumor markers Cyfra 21-1 and TPS in oral squamous cell carcinoma, Cancer, 85, 1018, 10.1002/(SICI)1097-0142(19990301)85:5<1018::AID-CNCR2>3.0.CO;2-R Newcomb, 1995, Postmenopausal hormone use and risk of large-bowel cancer, J Nat Cancer Inst, 87, 1067, 10.1093/jnci/87.14.1067 Nystrom, 1993, Breast cancer screening with mammography: An overview of the Swedish randomized trials, Lancet, 341, 973, 10.1016/0140-6736(93)91067-V O'Malley, 1987, US Preventative Services Task Force: Screening for breast cancer with self examination. A critical review, JAMA, 257, 2196, 10.1001/jama.257.16.2196 Oesterling, 1993, Influence of patient age on the serum PSA concentration. An important clinical observation, Urol Clin North Am, 4, 671 Oesterling, 1991, Prostate specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate, J Urol, 145, 907, 10.1016/S0022-5347(17)38491-4 Parker, 1998, Cancer statistics by race and ethnicity, CA Cancer J Clin, 48, 31, 10.3322/canjclin.48.1.31 Persson, 1997, Effect of estrogen and estrogen progestin replacement therapy regimens on mammographic breast parechymal density, J Clin Oncol, 15, 3201, 10.1200/JCO.1997.15.10.3201 Penninx, 1998, Chronically depressed mood and cancer risk in older persons, J Natl Cancer Inst, 90, 1888, 10.1093/jnci/90.24.1888 Pisano, 1998, Screening mammography behavior after a false positive mammogram, Cancer Detect Prev, 22, 161, 10.1046/j.1525-1500.1998.CDOA21.x Potter, 1993, Colon cancer: A review of the epidemiology, Epidemiol Rev, 15, 499, 10.1093/oxfordjournals.epirev.a036132 Pound, 1999, Natural history of progression after PSA elevation following radical prostatectomy, JAMA, 281, 1591, 10.1001/jama.281.17.1591 1996 Prorok, 1992, Epidemiologic approach for cancer screening: Problems in design and analysis of trials, Am J Pediatr Hematol/Oncol, 14, 117, 10.1097/00043426-199205000-00005 Reissigl, 1997, Prostate-specific antigen as a screening test. The Austrian experience, Urol Clin North Am, 24, 315, 10.1016/S0094-0143(05)70378-5 Ries, 1996 Remington, 1990, Cervical cancer deaths among older women: Implications for prevention, Wisconsin Medical Journal, 89, 32 Ries, 1998 Roberts, 1999, Decline in prostate cancer mortality from 1980 to 1997 (and an update on incidence trends in Olmsted County, Minnesota, J Urol, 16, 529, 10.1016/S0022-5347(01)61941-4 Robie, 1989, Cancer screening in the elderly, J Am Geriatr Soc, 37, 888, 10.1111/j.1532-5415.1989.tb02272.x Robinson, 1997, Cancer screening in the older patient, Clin Geriatr Med, 13, 97, 10.1016/S0749-0690(18)30185-X Rosen, 1985, Breast cancer at the extreme ages: A comparison of patients younger than 35 years and older than 75 years, J Surg Oncol, 28, 90, 10.1002/jso.2930280204 Rosenthal, 1998, p53 codon 72 polymorphism and risk of cervical cancer in UK, Lancet, 352, 871, 10.1016/S0140-6736(98)07357-7 Sackett, 1975, Controversy in the detection of disease, Lancet, 2, 357, 10.1016/S0140-6736(75)92790-7 Saenz, 1998, Breast cancer, Oncology, 25, 309 Satariano, 1994, The effect of cormorbidity on 3 year survival of women with primary breast cancer, Ann Intern Med, 120, 104, 10.7326/0003-4819-120-2-199401150-00002 Schaefer, 1984, Breast carcinoma in elderly women: Pathology, prognosis, survival, Pathology Annual, 9, 195 Schneider, 1996, Screening for cervical intraepithelial neoplasia grade 2/3: Validity of cytologic study, cervicography, and human papillomavirus detection, Am J Obstet Gynecol, 174, 1534, 10.1016/S0002-9378(96)70602-6 Schroder, 1998, Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer, J Natl Cancer Inst, 90, 1817, 10.1093/jnci/90.23.1817 Schwartz, 1992, Subclinical ductal carcinoma in situ of the breast: Treatment by local excision and surveillance alone, Cancer, 70, 2468, 10.1002/1097-0142(19921115)70:10<2468::AID-CNCR2820701013>3.0.CO;2-K The United States Preventive Force, 1994, Screening for Prostate cancer: Commentary on the recommendations of the Canadian Task Force on the Periodic Health Examinations, Am J Prev Med, 10, 187, 10.1016/S0749-3797(18)30589-0 Seamon, 1993, PSA density: Role in patient evaluation and management, Urol Clin North Am, 20, 653 Selby, 1992, A case control study of screening sigmoidoscopy and mortality from colorectal cancer, N Engl J Med, 326, 653, 10.1056/NEJM199203053261001 Shipley, 1999, Radiation therapy for clinically localized prostate cancer: A multi-institutional pooled analysis, JAMA, 281, 1598, 10.1001/jama.281.17.1598 Shapiro, 1988, Periodic Screening for Breast Cancer Sigurdsson, 1993, Effect of organized screening on the risk of cervical cancer: Evaluation of screening activity in Iceland 1964–1991, Int J Cancer, 54, 563, 10.1002/ijc.2910540408 Singer, 1999, Quality end of life care: Patients' perspectives, JAMA, 281, 163, 10.1001/jama.281.2.163 Singletary, 1993, Breast cancer in the elderly, Ann Surg, 218, 667, 10.1097/00000658-199321850-00013 Smith, 1997, Racial differences in operating characteristics of prostate cancer screening tests, J Urol, 158, 1861, 10.1016/S0022-5347(01)64147-8 Smith, 1995, Interexaminer variability of digital rectal examination in detecting prostate cancer, Urology, 45, 70, 10.1016/S0090-4295(95)96812-1 Solomon, 1998, Three-year prospective adherence to three breast cancer screening modalities, Prev Med, 27, 781, 10.1006/pmed.1998.0357 Sone, 1998, Mass screening for lung cancer with mobile spiral computed tomography scanner, Lancet, 351, 1242, 10.1016/S0140-6736(97)08229-9 1997 Steinberg, 1990, Family history and the risk of prostate cancer, Prostate, 17, 337, 10.1002/pros.2990170409 Stomper, 1996, Analysis of parenchymal density of mammograms in 1353 women 25–29 years old, AJR Am J Roentgenol, 167, 1261, 10.2214/ajr.167.5.8911192 Swanson, 1993, Breast cancer among black and white women in the 1980's: Changing patterns in the United States by race, age, extent of disease, Cancer, 72, 788, 10.1002/1097-0142(19930801)72:3<788::AID-CNCR2820720326>3.0.CO;2-C Sutton, 1998, Gynecologic health and disease, Med Clin North Am, 82, 223, 10.1016/S0025-7125(05)70605-2 Iscoe, 1998, Prostate cancer screening: Waiting for Godot, Canadian Medical Association Journal, 159, 1375 Tabar, 1992, Update of the Swedish two-country program of mammographic screening for breast cancer, Radiol Clin North Am, 30, 187 Thomas, 1993, Mammographic calcifications and risk of subsequent breast cancer, J Natl Cancer Inst, 85, 203, 10.1093/jnci/85.3.230 Trimble, 1994, Representation of older patients in cancer treatment trials, Cancer, 74, 2208, 10.1002/1097-0142(19941001)74:7+<2208::AID-CNCR2820741737>3.0.CO;2-# Underwood, 1991, African-American men. Perceptual determinants of early cancer detection and cancer risk reduction, Cancer Nurs, 14, 281 VanDam, 1998, Impairment of cognitive function in women receiving adjuvant treatment for high risk breast cancer: High dose versus standard dose chemotherapy, J Natl Cancer Inst, 90, 210, 10.1093/jnci/90.3.210 Van der Graf, 1987, False negative rates in cervical cytology, J Clin Pathol, 40, 438, 10.1136/jcp.40.4.438 Van Nagell, 1995, Ovarian cancer screening, Cancer, 76, 2086, 10.1002/1097-0142(19951115)76:10+<2086::AID-CNCR2820761330>3.0.CO;2-L Vernon, 1997, Participation in colorectal cancer screening: A review, J Natl Cancer Inst, 89, 1406, 10.1093/jnci/89.19.1406 Wagner, 1996, Cost-effectiveness of colorectal cancer screening in average-risk adults, 321 Walter, 1983, Estimation of the duration of the preclinical state using screening data, Am J Epidemiol, 118, 865, 10.1093/oxfordjournals.aje.a113705 Waterhouse, 1989, The use of transrectal prostatic ultrasonography in the evaluation of patients with prostatic carcinoma, J Urol, 141, 233, 10.1016/S0022-5347(17)40729-4 Welch, 1998, Diagnostic testing following screening mammography in the elderly, J Natl Cancer Inst, 90, 1389, 10.1093/jnci/90.18.1389 Wilson, 1964 Whittemore, 1992, Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US controlled studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group, Am J Epidemiol, 136, 1184, 10.1093/oxfordjournals.aje.a116427 Winawer, 1997, Colorectal cancer screening: Clinical guidelines and rationale, Gastroenterology, 112, 594, 10.1053/gast.1997.v112.agast970594 Winawer, 1993, Prevention of colorectal cancer by colonoscopic polypectomy: The National Polyp Study Workgroup, N Engl J Med, 329, 1977, 10.1056/NEJM199312303292701 Winawer, 1993, Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps, N Engl J Med, 328, 901, 10.1056/NEJM199304013281301 Wingo, 1995, Cancer Statistics 1995, Cancer, 5 World Health Organization, 1995 Wu, 1999, Meta-analysis: Dietary fat intake serum estrogen levels, and the risk of breast cancer, J Natl Cancer Inst, 91, 529, 10.1093/jnci/91.6.529 Yancik, 1989, Breast cancer in aging women: A population based study of contrasts in stage, surgery and survival, Cancer, 63, 976, 10.1002/1097-0142(19890301)63:5<976::AID-CNCR2820630532>3.0.CO;2-A Yuan, 1992, Effects of rectal examination, prostatic massage, ultrasonography and needle biopsy on serum prostate specific antigen levels, J Urology, 147, 810, 10.1016/S0022-5347(17)37392-5 Zeitman, 1998, Radiation therapy or prostatectomy? An old conflict revisited in the PSA era: A radiation oncologist's viewpoint, Semin Radiat Oncol, 8, 81, 10.1016/S1053-4296(98)80003-9